Stocks making the biggest moves in the premarket: GlaxoSmithKline, CureVac, Airbnb and more

Stocks making the biggest moves in the premarket: GlaxoSmithKline, CureVac, Airbnb and more

(GSK) – The drugmaker's U.S.-listed shares jumped 3.1% in the premarket following a Bloomberg report that the company's $54 billion consumer products unit is attracting buyout interest from private-equity firms. Glaxo would only say it is "far advanced" with plans to separate the consumer business. (CVAC) – The drugmaker's shares tumbled 15.5% in the premarket after the company said it would discontinue the development of its most advanced Covid-19 vaccine candidate. The decision came after the European Medicines Agency told the company it would not fast-track the approval process. (ABNB) – Cowen upgraded Airbnb to "outperform" from "market perform," saying the Street is underestimating 2022 bookings growth and that the increase in alternative lodging will be a permanent part of the travel landscape. Airbnb shares gained 2.4% in the premarket. (SIG) – The jewelry retailer announced the acquisition of rival Diamonds Direct for $490 million in cash, and said the deal would add immediately to earnings. Signet rallied 3.1% in premarket action. (NKE) – Nike rose 1.3% in premarket trading after Goldman Sachs initiated coverage with a "buy" rating, citing a healthy industry backdrop as well as strong growth initiatives by the athletic footwear and apparel maker. (FAST) – The